Burges Salmon has supported Indian law firm Khaitan & Co, part of Burges Salmon’s International Preferred Firm Network, in advising its client Firstsource Solutions UK Limited, a London-based business process services firm and a wholly owned subsidiary of Firstsource Solutions Limited (Ind
Burges Salmon
Burges Salmon has been unveiled as Space Scotland’s first corporate sponsor. Operating within a market contributing in excess of £4 billion per year to the Scottish economy, Space Scotland is heavily involved in the delivery of the government’s Scottish Space Strategy.
Burges Salmon partner Magnus Miller considers the differences between pensions law in Scotland and in England. With the enactment of the Trust and Succession (Scotland) Act 2024 earlier this year, it is a good time to remind ourselves of the differences between Scots law and English law as they appl
Burges Salmon has guided Pandox on its financing and acquisition of the DoubleTree by Hilton Edinburgh City Centre, in a deal worth £49 million. The deal grows the international hotel property owner's portfolio in Scotland and adds to its Edinburgh offering where it already owns the Aparthotel
Trainees and NQs at Burges Salmon in Edinburgh have received salary boosts. The changes, which took effect at the beginning of September, mean that first year trainees, who were previously on £34,000 will now receive £40,000.
Burges Salmon has reported a 27 per cent increase in turnover to £163 million and a 46 per cent increase in net profit to £50.5 million. The independent UK law firm, which recently celebrated the fifth anniversary of its Edinburgh office, today published its results for the financial yea
Burges Salmon has advised Clean Energy Cap Ltd (CEC), a private-wire renewable energy company, on an investment from True Green Capital Management LLC (TGC), a renewable energy-focused private equity firm. An Edinburgh-based Burges Salmon corporate energy M&A team advised on the transaction, led
Burges Salmon, which has an office in Edinburgh, has retained its Platinum ‘We invest in people’ accreditation, following its initial accreditation in 2021. The Investors in People report commended Burges Salmon’s ‘people first’ culture and open and transparent communic
Burges Salmon has announced the appointment of Magnus Miller as a partner in its dispute resolution team, based in Edinburgh. Mr Miller is a seasoned litigator with experience in advising on a wide range of real estate disputes and commercial litigation matters across both the public and private sec
Burges Salmon has advised Export Development Canada (EDC) and NatWest on the long-term financing of a 106MW wind farm, located in Caithness. Acting as co-mandated lead arrangers and co-lenders, EDC and NatWest together provided £130 million to support the construction of the Limekiln Wind Farm
Burges Salmon is celebrating its five-year anniversary in Scotland since the opening of its Edinburgh office in Atria One, on Morrison Street, in May 2019. The firm's corporate team has also been particularly active in the market, working with leading life sciences and biotech companies including Ed
Burges Salmon has advised Calcivis, a Scottish biotech that aims to revolutionise early-intervention diagnostics in dentistry, on its £5 million investment. The funding was provided by the Scottish National Investment Bank and IFS Maven Equity Finance, which is managed by Maven Capital Partner
Burges Salmon has advised Santander on a deal to support the Management Buy-Out (MBO) of Scottish pensions firm @sipp. Based in Glasgow, @sipp specialises in self-invested personal pensions, small self-administered schemes as well as commercial property. Supported by funding provided by Santander UK
Burges Salmon has appointed Mairi Carlin to its pensions and lifetime savings practice.
Burges Salmon has advised cancer therapeutics company Cumulus Oncology Limited on the £9 million funding package it secured from the Scottish National Investment Bank and Eos Advisory. An Edinburgh-based team from Burges Salmon’s corporate and M&A team advised Cumulus Oncology, led b